Maude Tessier
About Maude Tessier
Maude Tessier Chief Business Officer
Maude Tessier currently holds the position of Chief Business Officer. In this role, she oversees multiple aspects essential to the company's growth, including business development, legal, and corporate strategy functions. Her leadership and strategic vision have been instrumental in forming valuable partnerships and securing significant funding. Tessier's expertise in negotiating high-stake deals and driving core financing activities demonstrate her ability to navigate the complex landscape of the biopharmaceutical industry.
Maude Tessier Education and Expertise
Maude Tessier holds a PhD from the Department of Medical Biophysics at the University of Toronto, showcasing her strong foundation in scientific research and medical studies. Additionally, she earned an Honors Great Distinction BSc in Biochemistry from McGill University. Tessier's educational background provides her with the technical acumen necessary for her work in business development and licensing within the biopharmaceutical sector.
Maude Tessier Background in Business Development
Maude Tessier has extensive experience in business development, starting her career at Xanthus Pharmaceuticals, where she contributed to the business development and program management of a Phase 3 drug candidate. Her career trajectory includes significant roles such as Executive Director, Business Development and Licensing at Merck & Co, where she focused on oncology and immunology in the Boston innovation hub. Tessier's background displays a consistent focus on building strategic partnerships and advancing clinical programs through various stages of development.
Maude Tessier Strategic Partnerships and Financing
While serving as Chief Business Officer at Ikena Oncology, Maude Tessier led the negotiation of a $1 billion+ strategic partnership with Bristol-Myers Squibb (BMS). She also drove core financing activities that resulted in over $260 million in private and public capital. Tessier's strategic initiatives and robust negotiation skills have played a crucial role in accelerating the company's growth and expanding its operational capabilities.
Maude Tessier Professional Involvement and Mentorship
Outside of her executive roles, Maude Tessier serves as a co-chair of the Boston Biobreak CBO forum, a platform for Chief Business Officers to share insights and strategies. She is also an investment advisory board member for the Brown University Biomedical Innovations to Impact Fund and mentors for Endless Frontier Labs. Her involvement in these additional roles reflects her commitment to fostering innovation and providing guidance to emerging leaders in the biopharmaceutical industry.